Cargando…
Glycolipid‐peptide conjugate vaccines elicit CD8 (+) T‐cell responses and prevent breast cancer metastasis
OBJECTIVES: Metastasis is the principal cause of breast cancer mortality. Vaccines targeting breast cancer antigens have yet to demonstrate clinical efficacy, and there remains an unmet need for safe and effective treatment to reduce the risk of metastasis, particularly for people with triple‐negati...
Autores principales: | Burn, Olivia K, Farrand, Kathryn, Pritchard, Tara, Draper, Sarah, Tang, Ching‐wen, Mooney, Anna H, Schmidt, Alfonso J, Yang, Sung H, Williams, Geoffrey M, Brimble, Margaret A, Kandasamy, Matheswaran, Marshall, Andrew J, Clarke, Kate, Painter, Gavin F, Hermans, Ian F, Weinkove, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250805/ https://www.ncbi.nlm.nih.gov/pubmed/35795321 http://dx.doi.org/10.1002/cti2.1401 |
Ejemplares similares
-
Glycolipid-peptide conjugate vaccines enhance CD8(+) T cell responses against human viral proteins
por: Speir, M., et al.
Publicado: (2017) -
NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
por: Anderson, Regan J., et al.
Publicado: (2015) -
Harnessing NKT cells for vaccination
por: Burn, Olivia K, et al.
Publicado: (2021) -
Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy
por: Jarvis, Ellie-May, et al.
Publicado: (2021) -
6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria
por: Meijlink, Michael A., et al.
Publicado: (2022)